Compare Oklo Inc (OKLO) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oklo Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Oklo Inc trades at $35.05 (market cap $6.85B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Oklo Inc is far larger — about 3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals.
| OKLO | SLS | |
|---|---|---|
Market Cap | $6.85B | $2.28B |
Volume | 11,387,867 | 3,128,960 |
Sector | Utilities | Health |
52-Week High | $174.14 | $15.46 |
52-Week Low | $34.57 | $1.39 |
Typical Hold Time | 31 Days | — |
Enterprise Value | $4.39B | $2.15B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OKLO trades at $36.82, down 4.49% on the day, with bearish technical indicators showing resistance at $37-38. The company shows no revenue in 2025 and negative net income of -$105.66M, though analyst consensus remains strongly bullish with a $78.63 price target. Recent news highlights nuclear energy sector momentum but notes OKLO's early commercialization stage and recent $1 billion stock sale.
Outlook hinges on project pipeline execution amid substantial cash burn. High institutional support via financing ($1.26B in 2025) fuels growth bets, but profitability remains distant with a -12,625.54% net margin. Risks include dilution from equity raises and intense SMR competition. The stock offers speculative upside if contracts materialize but carries high volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
